WOBURN, Mass.--Emerging genomics company AlphaGene here announced the appointment of John Zabriskie and Steven Hochberg to its board of directors last week. Zabriskie, former president and CEO of Pharmacia and Upjohn, is chairman and president of NEN Life Science Products, a supplier of reagents for labeling and detection of DNA, RNA, and proteins. Hochberg is a partner and managing director of ProMed Management, a private investment group involved in significant healthcare and biomedical financings.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.